InvestorsHub Logo
Followers 3
Posts 253
Boards Moderated 0
Alias Born 08/23/2007

Re: None

Friday, 07/20/2018 6:14:22 PM

Friday, July 20, 2018 6:14:22 PM

Post# of 9810
Ricin to the challenge: Soligenix is 'only game' now...

In biodefense, a PRV may be awarded upon the product's approval as a medical countermeasure when the active ingredient(s) have not been otherwise cleared for use in any context. PRVs are transferable and can be sold, with sales in recent years ranging between $125 million to $350 million.

That translates to:

125,000,00 = $7.25 a share up-to 350,000,00 = $ 22.25 a share...

http://www.bioworld.com/content/ricin-challenge-soligenix-only-game-now

Sngx Management Team, Perhaps Europe can use RICIN against Putin and his desire for a new Russian empire and believe me he won’t stop with Ukraine...

Maps just my own opinion...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News